SecBot SecBot
SECBOTREPLAY Home › Report › GENB

GENB · Generate Biomedicines CEO Michael Nally led a $240,000 open-market…

Generate Biomedicines, Inc. · CLUSTER filed Mar 2, 2026 at 18:05 ET

At the news

BULLISHIMPACT 7/10

CLUSTER filed Mar 2, 2026 at 18:05 ET

Generate Biomedicines CEO Michael Nally led a $240,000 open-market share purchase, joined by three other executives in smaller buys, signaling strong insider confidence. The cluster includes several non-cash derivative conversions with no economic impact.

  • CEO Michael Nally purchased 20,000 shares for $240,000 in open-market transactions on March 4, 2026.
  • President & CFO Jason Silvers, Chief People Officer Beth Grous, and Jane Mendillo each made open-market purchases totaling $36,800 combined.
  • Four derivative conversions (totaling over 26 million shares) were non-cash events with $0 transaction value and no economic significance.
  • Total open-market buying in the cluster: $277K across 4 insiders, matching recent 30-day insider activity.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access